ACY-241: Preliminary Phase I data

Preliminary data from 7 relapsed or relapsed/refractory MM patients previously treated with >=2 cycles of Revlimid lenalidomide and a proteasome inhibitor in the open-label, U.S. Phase Ia/Ib ACE-MM-2...